Carvedilol Tablet, Film Coated
Product Images NDC 71610-062

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 71610-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label 3.125 mg (71610 0062 53)

Bottle Label 3.125 mg (71610 0062 53)
Carvedilol 3.125 mg film-coated tablets label showing a 60-tablet bottle. The label includes storage instructions, repackaging information by Aphena Pharma Solutions - Tennessee, LLC, and manufacturing details by Beximco Pharmaceuticals Ltd. The label states the product is for oral use and prescription only.*
FDA Label Image

Bottle Label 6.25 mg (71610 0063 53)

Bottle Label 6.25 mg (71610 0063 53)
Label for Carvedilol 6.25 mg film-coated tablets, oral dosage form, containing 60 tablets per bottle. The label states storage instructions, manufacturer Beximco Pharmaceuticals Ltd. in Tongi, Bangladesh, and repackager Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. The label includes multiple barcodes and is marked Rx Only.*
FDA Label Image

Bottle Label 12.5 mg (71610 0066 60)

Bottle Label 12.5 mg (71610 0066 60)
Carvedilol 12.5 mg film-coated tablets label showing a package containing 90 tablets. The label includes the product name, strength, quantity, manufacturer information for Beximco Pharmaceuticals Ltd. in Bangladesh, and repackaging information by Aphena Pharma Solutions - Tennessee, LLC. The label also features storage instructions and a barcode.*
FDA Label Image

Bottle Label 25 mg (71610 0067 60)

Bottle Label 25 mg (71610 0067 60)
Label for Carvedilol 25 mg film-coated tablets, containing 90 tablets. The label states the dosage strength, quantity, and that the product is prescription only. It includes storage instructions, manufacturer information listing Beximco Pharmaceuticals Ltd. in Tongi, Bangladesh, and repackaging details by Aphena Pharma Solutions - Tennessee, LLC. The label also displays the NDC number 71610-0067-60 and batch and expiration details.*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A line chart comparing percent mortality over 21 months between Carvedilol and placebo groups. The vertical axis shows % mortality, and the horizontal axis represents time in months. The graph displays lower mortality for the Carvedilol group relative to placebo, with a P-value of 0.0014 indicating statistical significance.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A forest plot chart displaying hazard ratios for various patient subgroups, including men, women, age groups, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and spironolactone use, with a vertical line at hazard ratio 1.0 for reference.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A line graph depicting percentage mortality over 24 months comparing Carvedilol tablets to placebo. The graph shows two distinct curves, with Carvedilol demonstrating a lower mortality rate than placebo, accompanied by a p-value of 0.03 indicating statistical significance.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
A forest plot illustrating hazard ratios with 95% confidence intervals for various patient subgroups, including age, gender, randomized treatment days, prior IV/oral beta-blocker use, Killip classification, thrombolytic status, PTCA for MI, CHF history, diuretics use during MI, angina presence, hypertension, diabetes, heart rate, systolic blood pressure, and overall patient population. The plot visually compares these factors against a reference hazard ratio line at 1.0.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure diagram of Carvedilol showing its molecular composition and arrangement, including multiple aromatic rings, an ether linkage, and a hydroxy group, consistent with the active ingredient Carvedilol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.